X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
female (3) 3
heterogeneity (3) 3
humans (3) 3
biopsy (2) 2
inhibition (2) 2
male (2) 2
map kinase signaling system (2) 2
middle aged (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
whole exome sequencing (2) 2
acquired resistance (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
alterations (1) 1
animals (1) 1
anti-egfr therapy (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
article (1) 1
autopsies (1) 1
autopsy (1) 1
biochemistry & molecular biology (1) 1
blockade (1) 1
braf (1) 1
carcinoma, pancreatic ductal - drug therapy (1) 1
carcinoma, pancreatic ductal - genetics (1) 1
case reports (1) 1
cell biology (1) 1
cell line, tumor (1) 1
cell-free dna (1) 1
cell-free nucleic acids - blood (1) 1
cell-free nucleic acids - genetics (1) 1
cohort studies (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - enzymology (1) 1
colorectal neoplasms - genetics (1) 1
colorectal neoplasms - metabolism (1) 1
colorectal-cancer (1) 1
data acquisition (1) 1
deoxyribonucleic acid--dna (1) 1
dna (1) 1
dna repair (1) 1
dna, neoplasm - blood (1) 1
dna, neoplasm - genetics (1) 1
drug resistance, neoplasm (1) 1
drug resistance, neoplasm - genetics (1) 1
ductal adenocarcinoma (1) 1
evolution (1) 1
fibroblasts (1) 1
gastrointestinal neoplasms - blood (1) 1
gastrointestinal neoplasms - genetics (1) 1
gastrointestinal neoplasms - pathology (1) 1
gene expression profiling - methods (1) 1
gene expression regulation, neoplastic (1) 1
gene regulatory networks (1) 1
genetic heterogeneity (1) 1
genetic variation (1) 1
genomic landscape (1) 1
genomics - methods (1) 1
germ-line mutation (1) 1
homologous recombination (1) 1
intratumor heterogeneity (1) 1
lesions (1) 1
liquid biopsy (1) 1
medicine, research & experimental (1) 1
mek (1) 1
mice (1) 1
mice, nude (1) 1
mutation (1) 1
mutation, missense (1) 1
mutations (1) 1
oncology (1) 1
pancreatic neoplasms - drug therapy (1) 1
pancreatic neoplasms - genetics (1) 1
precision medicine (1) 1
protein kinase inhibitors - pharmacology (1) 1
proto-oncogene proteins b-raf - antagonists & inhibitors (1) 1
proto-oncogene proteins b-raf - metabolism (1) 1
resistance (1) 1
sequence analysis, rna - methods (1) 1
sequences (1) 1
signature (1) 1
somatic ercc2 mutations (1) 1
subtypes (1) 1
target acquisition (1) 1
targeted therapy (1) 1
therapy (1) 1
tumors (1) 1
whole exome sequencing - methods (1) 1
xenograft model antitumor assays (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 11/2019
Although represents the most commonly mutated oncogene, it has long been considered an "undruggable" target. Novel covalent inhibitors selective for the KRAS... 
Journal Article
NATURE MEDICINE, ISSN 1078-8956, 09/2019, Volume 25, Issue 9, pp. 1415 - 1415
Journal Article
Cancer Discovery, ISSN 2159-8274, 09/2018, Volume 8, Issue 9, pp. 1096 - 1111
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2018, Volume 8, Issue 4, pp. 417 - 427
Clonal heterogeneity associated with acquired resistance presents a critical therapeutic challenge. Whole-exome sequencing of paired tumor biopsies and... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2019
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1575 - 1575
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 01/2020
ctDNA offers a promising, noninvasive approach to monitor therapeutic efficacy in real-time. We explored whether the quantitative percent change in ctDNA early... 
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 06/2017, Volume 28 Suppl 3, p. iii137
Journal Article
JCO Precision Oncology, ISSN 2473-4284, 11/2018, Issue 2, pp. 1 - 15
Purpose Third-generation epidermal growth factor receptor (EGFR) inhibitors like nazartinib are active against EGFR mutation–positive lung cancers with... 
Journal Article
JCO precision oncology, ISSN 2473-4284, 2018, Volume 2018
Third-generation epidermal growth factor receptor (EGFR) inhibitors like nazartinib are active against mutation-positive lung cancers with T790M-mediated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.